Renaissance Technologies (RenTech)'s TNYA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 4.28 M shares of Tenaya Therapeutics, Inc. (TNYA) worth $3.16 M, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in TNYA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 1.86 M shares. Largest reduction occurred in Q1 2024, reducing 417,825 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Tenaya Therapeutics (TNYA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tenaya Therapeutics (TNYA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +567,339 | Add 15.28% | 4.28 M | $0.74 |
| Q1 2026 | +1.86 M | Add 100.65% | 3.71 M | $0.69 |
| Q4 2025 | +172,665 | Add 10.29% | 1.85 M | $0.71 |
| Q3 2025 | -165,677 | Reduce 8.99% | 1.68 M | $1.62 |
| Q2 2025 | +302,154 | Add 19.60% | 1.84 M | $0.61 |
| Q1 2025 | +1.54 M | New Buy | 1.54 M | $0.57 |
| Q4 2024 | -380,468 | Sold Out | 0 | $0.00 |
| Q3 2024 | +223,008 | Add 141.63% | 380,468 | $1.93 |
| Q2 2024 | +92,960 | Add 144.12% | 157,460 | $3.10 |
| Q1 2024 | -417,825 | Reduce 86.63% | 64,500 | $5.22 |
| Q4 2023 | +48,725 | Add 11.24% | 482,325 | $3.24 |
| Q3 2023 | +339,800 | Add 362.26% | 433,600 | $2.55 |
| Q2 2023 | -171,100 | Reduce 64.59% | 93,800 | $0.01 |
| Q1 2023 | +55,821 | Add 26.70% | 264,900 | $0.00 |
| Q4 2022 | +42,879 | Add 25.80% | 209,079 | $0.00 |
| Q3 2022 | +166,200 | New Buy | 166,200 | $2.90 |
Renaissance Technologies (RenTech)'s Tenaya Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Tenaya Therapeutics, Inc. (TNYA) in Q3 2022, acquiring 166,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Tenaya Therapeutics, Inc. (TNYA) for 16 quarters since Q3 2022.
Renaissance Technologies (RenTech)'s largest addition to Tenaya Therapeutics, Inc. (TNYA) was in Q1 2026, adding 3,713,761 shares worth $2.57 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 4,281,100 shares of Tenaya Therapeutics, Inc. (TNYA), valued at approximately $3.16 M.
As of the Q2 2026 filing, Tenaya Therapeutics, Inc. (TNYA) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Tenaya Therapeutics, Inc. (TNYA) was 4,281,100 shares, as reported at the end of Q2 2026.